Impact of HPV in Oropharyngeal Cancer
2011

Impact of HPV in Oropharyngeal Cancer

publication Evidence: moderate

Author Information

Author(s): Linda Marklund, Lalle Hammarstedt

Primary Institution: Karolinska University Hospital

Hypothesis

HPV is a significant risk factor for the increasing incidence of oropharyngeal cancer.

Conclusion

HPV-positive oropharyngeal cancers have a better prognosis and response to treatment compared to HPV-negative cancers.

Supporting Evidence

  • HPV-positive tumors are recognized as a distinct subset of head and neck cancers with improved prognosis.
  • HPV-positive oropharyngeal cancer patients show an 80-95% overall survival rate compared to 57-62% for HPV-negative patients.
  • HPV status is a significant prognostic factor for treatment response and overall survival.

Takeaway

This study shows that a virus called HPV can make some throat cancers more common, but those cancers are often easier to treat and have better outcomes.

Methodology

This is a review article summarizing current knowledge regarding HPV biology, oncogenic mechanisms, risk factors, and treatment impacts.

Limitations

The natural history and tumor development biology of HPV-infection in head and neck tumors are not yet fully understood.

Digital Object Identifier (DOI)

10.1155/2011/509036

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication